Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively improved hair loss in a teenage girl with androgenetic alopecia.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Long-term use of minoxidil may cause hair follicles to transform into noticeable terminal hairs, leading to trichostasis spinulosa.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

Traumatic alopecia causes hair loss from pulling or rubbing, leading to broken hairs and changes in the scalp.

The woman has unexplained hair loss and it's unclear what her condition is or how to treat it.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

A new tool makes hair transplant surgeries faster by creating multiple cuts in one go.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

A woman got male pattern baldness from touching her husband's testosterone gel.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Aromatase inhibitors cause male pattern hair loss in women.

Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Finasteride improves hair loss in women with hyperandrogenism.

Women with thinning hair have thinner hair strands than women without hair loss.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Bleaching hair removes its protective top layer and exposes more hydrophilic groups, changing its chemical surface and affecting how it interacts with products.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.